| Field | Row 1 |
|---|---|
| adsh | 0001140361-25-019266 |
| cik | 1228627 |
| name | OPUS GENETICS, INC. |
| sic | 2834 |
| countryba | US |
| stprba | NC |
| cityba | DURHAM |
| zipba | 27709 |
| bas1 | 8 DAVIS DRIVE |
| bas2 | SUITE 220 |
| baph | 248-681-9815 |
| countryma | US |
| stprma | NC |
| cityma | DURHAM |
| zipma | 27709 |
| mas1 | 8 DAVIS DRIVE |
| mas2 | SUITE 220 |
| countryinc | US |
| stprinc | DE |
| ein | 113516358 |
| former | OCUPHIRE PHARMA, INC. |
| changed | 20201109 |
| afs | 4-NON |
| wksi | 0 |
| fye | 1231 |
| form | 10-Q |
| period | 20250331 |
| fy | 2025 |
| fp | Q1 |
| filed | 20250515 |
| accepted | 2025-05-15 16:02:00.0 |
| prevrpt | 0 |
| detail | 1 |
| instance | ef20047563_10q_htm.xml |
| nciks | 1 |
| aciks |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| cik | Central Index Key (CIK). Ten digit number assigned by the SEC to each registrant that submits filings. |
| name | Name of registrant. This corresponds to the name of the legal entity as recorded in EDGAR as of the filing date. |
| sic | Standard Industrial Classification (SIC). Four digit code assigned by the SEC as of the filing date, indicating the registrant’s type of business. |
| countryba | The ISO 3166-1 country of the registrant's business address. |
| stprba | The state or province of the registrant’s business address, if field countryba is US or CA. |
| cityba | The city of the registrant's business address. |
| zipba | The zip code of the registrant’s business address. |
| bas1 | The first line of the street of the registrant’s business address. |
| bas2 | The second line of the street of the registrant’s business address. |
| baph | The phone number of the registrant’s business address. |
| countryma | The ISO 3166-1 country of the registrant's mailing address. |
| stprma | The state or province of the registrant’s mailing address, if field countryma is US or CA. |
| cityma | The city of the registrant's mailing address. |
| zipma | The zip code of the registrant’s mailing address. |
| mas1 | The first line of the street of the registrant’s mailing address. |
| mas2 | The second line of the street of the registrant’s mailing address. |
| countryinc | The ISO 3166-1 country of incorporation for the registrant. |
| stprinc | The state or province of incorporation for the registrant, if countryinc is US or CA. |
| ein | Employee Identification Number, 9 digit identification number assigned by the Internal Revenue Service to business entities operating in the United States. |
| former | Most recent former name of the registrant, if any. |
| changed | Date of change from the former name, if any. |
| afs | Filer status with the SEC at the time of submission: 1-LAF=Large Accelerated, 2-ACC=Accelerated, 3-SRA=Smaller Reporting Accelerated, 4-NON=Non-Accelerated, 5-SML=Smaller Reporting Filer, NULL=not assigned. |
| wksi | Well Known Seasoned Issuer (WKSI). An issuer that meets specific SEC requirements at some point during a 60-day period preceding the date the issuer satisfies its obligation to update its shelf registration statement. |
| fye | Fiscal Year End Date, rounded to nearest month-end. |
| form | The submission type of the registrant’s filing. |
| period | Balance Sheet Date, rounded to nearest month-end. |
| fy | Fiscal Year Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8). |
| fp | Fiscal Period Focus (as defined in the EDGAR XBRL Guide Ch. 3.1.8) within Fiscal Year. |
| filed | The date of the registrant’s filing with the Commission. |
| accepted | The acceptance date and time of the registrant’s filing with the Commission. |
| prevrpt | Previous Report – TRUE indicates that the submission information was subsequently amended. |
| detail | TRUE indicates that the XBRL submission contains quantitative disclosures within the footnotes and schedules at the required detail level (e.g., each amount). |
| instance | The name of the submitted XBRL Instance Document. The name often begins with the company ticker symbol. |
| nciks | Number of Central Index Keys (CIK) of registrants (i.e., business units) included in the consolidating entity’s submitted filing. |
| aciks | Additional CIKs of co-registrants included in a consolidating entity’s EDGAR submission, separated by spaces. If there are no other co-registrants (i.e., nciks=1), the value of aciks is NULL. For a very small number of filers, the entire list of co-registrants is too long to fit in the field. Where this is the case, users should refer to the complete submission file for all CIK information. |
| adsh | ddate | tag | value | uom | qtrs | version | segments | coreg | footnote |
|---|---|---|---|---|---|---|---|---|---|
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 985000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20241231 | Assets | 36862000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Cash And Cash Equivalents At Carrying Value | 30321000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Common Stock Shares Issued | 31574657.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Common Stock Shares Outstanding | 31574657.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Derivative Liabilities Current | 2000000.0000 | USD | 0 | us-gaap/2024 | Restatement= Revision Of Prior Period Reclassification Adjustment; | ||
| 0001140361-25-019266 | 20250331 | Derivative Liabilities Current | 2000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Other Derivative Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -8194000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 1730000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Increase Decrease In Contract Assets And Unbilled Receivables | -534000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Liabilities And Stockholders Equity | 48167000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Net Income Loss | -8194000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20240331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Other Nonoperating Income Expense | 602000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Payments Of Stock Issuance Costs | 165000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20250331 | Payments Of Stock Issuance Costs | 1413000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Payments Of Stock Issuance Costs | 0.2000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20241231 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Warrants In Connection With Private Offering And Private Placement | 15520000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Stock Options Exercised | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Property Plant And Equipment Net | 239000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Research And Development Expense Excluding Acquired In Process Cost | 4749000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1711000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Share Based Compensation | 913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Shares Outstanding | 31574657.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stockholders Equity | 5000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Of Private Offering And Private Placement | 5980000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Of Private Offering And Private Placement | 5979000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 5000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 18843000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Temporary Equity Shares Outstanding | 14145.3740 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20240331 | Unpaid Issuance Costs | 104000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20240331 | Warrant Financing Costs Reclassified To Financing Activities | 0.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20240331 | Weighted Average Number Of Diluted Shares Outstanding | 24520475.0000 | shares | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Weighted Average Number Of Diluted Shares Outstanding | 33884920.0000 | shares | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Accounts Receivable Net Current | 3080000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Accounts Receivable Net Current | 3563000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Accrued Liabilities And Other Liabilities | 8147000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 165000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 165000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | -3340000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Comprehensive Income Net Of Tax | -7106000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Depreciation | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Derivative Liabilities Current | 2000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Other Derivative Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | Derivative Liabilities Current | 12715000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Derivative Financial Instruments Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | Earnings Per Share Basic | -0.2400 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | General And Administrative Expense | 4670000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Increase Decrease In Accounts Payable | -89000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Increase Decrease In Accounts Receivable | 998000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Increase Decrease In Accounts Receivable | -483000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | 272000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Liabilities Current | 11295000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Net Cash Provided By Used In Operating Activities | -8994000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Operating Income Loss | -9929000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Other Comprehensive Income Loss Net Of Tax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Other Nonoperating Income Expense | 302000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Payments Of Stock Issuance Costs | 61000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Payments Of Stock Issuance Costs | 0.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20250331 | Preferred Stock Shares Authorized | 9985854.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock | 26800000.0000 | USD | 16 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20231231 | Stockholders Equity | 131370000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20240331 | Stockholders Equity | 46057000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Stockholders Equity | 6724000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 2478000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20231231 | Temporary Equity Carrying Amount Attributable To Parent | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 18843000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Shares Authorized | 14146.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20241031 | Temporary Equity Shares Issued | 14145.3740 | shares | 0 | us-gaap/2024 | Business Acquisition= Opus Genetics Inc; Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Unpaid Issuance Costs | 687000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | 11471000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 865000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Interest Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Liabilities | 24251000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Income Loss | -7106000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Net Income Loss | -8194000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241031 | Preferred Stock Shares Outstanding | 14145.3740 | shares | 0 | us-gaap/2024 | Business Acquisition= Opus Genetics Inc; | ||
| 0001140361-25-019266 | 20241231 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Proceeds From Issuance Of Common Stock | 2200000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20241231 | Retained Earnings Accumulated Deficit | -138998000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 4370000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Share Based Compensation | 985000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Short Term Investments | 2000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stockholders Equity | 152260000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Shares At The Market Program And Purchase Agreement | 352953.0000 | shares | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Shares Stock Options Exercised | 0.0000 | shares | 1 | us-gaap/2024 | Plan Name= Equity Incentive Plan2018; | ||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 2479000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 1000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 409000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 1000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 5000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Unrealized Gain Loss On Investments | -1000.0000 | USD | 1 | us-gaap/2024 | Fair Value By Asset Class= Short Term Investments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20240331 | Weighted Average Number Of Shares Outstanding Basic | 24520475.0000 | shares | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Accounts Payable Current | 3148000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Additional Paid In Capital | 145719000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Cash And Cash Equivalents At Carrying Value | 41792000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001140361-25-019266 | 20250331 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Common Stock Shares Issued | 45483823.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Contract Assets And Unbilled Receivables Current | 1675000.0000 | USD | 0 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20231231 | Derivative Liabilities Current | 74000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Other Derivative Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20241231 | Derivative Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Earnings Per Share Diluted | -0.2900 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Financing Costs | 1372000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Gain Loss On Derivative Instruments Net Pretax | 2805000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Increase Decrease In Accounts Payable | -718000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Increase Decrease In Contract Assets And Unbilled Receivables | -213000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Liabilities Current | 24251000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Payments Of Stock Issuance Costs | 1300000.0000 | USD | 16 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20250331 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Proceeds From Issuance Of Common Stock | 2479000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock | 409000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Proceeds From Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Share Repurchases For Payment Of Employee Taxes | 36000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20231231 | Shares Outstanding | 23977491.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Shares Outstanding | 25085592.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Shares Of Private Offering And Private Placement | 13396207.0000 | shares | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 408000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20240331 | Unrealized Gain Loss On Investments | -10000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Weighted Average Number Of Shares Outstanding Basic | 33884920.0000 | shares | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 985000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 913000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 42000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 36000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Common Stock Shares Outstanding | 45483823.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Liabilities And Stockholders Equity | 36862000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Income Loss | -7106000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Net Income Loss | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20241231 | Preferred Stock Value | 0.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock | 5200000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock | 400000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= At The Market Program; | ||
| 0001140361-25-019266 | 20240331 | Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Connection With Private Offering And Private Placement | 0.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20241231 | Property Plant And Equipment Net | 252000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Stockholders Equity | 134626000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20241231 | Stockholders Equity | -138998000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Of Private Offering And Private Placement | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Shares Issued | 14145.3740 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20240331 | Unrealized Gain Loss On Investments | -10000.0000 | USD | 1 | us-gaap/2024 | Fair Value By Asset Class= Short Term Investments; Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level1; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | Warrant Financing Costs Reclassified To Financing Activities | 1372000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20241231 | Accrued Liabilities And Other Liabilities | 2000000.0000 | USD | 0 | us-gaap/2024 | Restatement= Revision Of Prior Period Reclassification Adjustment; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 42000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Assets Current | 47928000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 47161000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 41792000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Comprehensive Income Net Of Tax | -8194000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Contract Assets And Unbilled Receivables Current | 2209000.0000 | USD | 0 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Depreciation | 13000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Derivative Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Derivative Financial Instruments Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | Derivative Liabilities Current | 12715000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Earnings Per Share Diluted | -0.2400 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Gain Loss On Derivative Instruments Net Pretax | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Income Tax Expense Benefit | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Increase Decrease In Prepaid Deferred Expense And Other Assets | 461000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Cash Provided By Used In Operating Activities | -5716000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Operating Income Loss | -7708000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Preferred Stock Shares Authorized | 9985854.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Preferred Stock Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Prepaid Expense And Other Assets Current | 515000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Prepaid Expense And Other Assets Current | 1380000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Proceeds From Issuance Of Common Stock | 300000.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20240331 | Revenue From Contract With Customer Excluding Assessed Tax | 1711000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Viatris License Agreement; | ||
| 0001140361-25-019266 | 20231231 | Stockholders Equity | 2000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20241231 | Stockholders Equity | 145719000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20241231 | Stockholders Equity | 3000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stockholders Equity | 5073000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Value At The Market Program And Purchase Agreement | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Unrealized Gain Loss On Investments | -1000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Accounts Payable Current | 2430000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Accrued Liabilities And Other Liabilities | 9106000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Additional Paid In Capital | 152260000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20241231 | Assets Current | 36610000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Common Stock Shares Authorized | 125000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241031 | Common Stock Shares Outstanding | 31435507.0000 | shares | 0 | us-gaap/2024 | Business Acquisition= Opus Genetics Inc; | ||
| 0001140361-25-019266 | 20241231 | Common Stock Value | 3000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20231231 | Derivative Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Derivative Financial Instruments Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20241231 | Derivative Liabilities Current | 0.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Derivative Financial Instruments Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20250331 | General And Administrative Expense | 6346000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Net Cash Provided By Used In Financing Activities | 2376000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Net Cash Provided By Used In Financing Activities | 20465000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Operating Expenses | 9419000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Payments Of Stock Issuance Costs | 1400000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20250331 | Payments Of Stock Issuance Costs | 0.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20250331 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock | 0.0000 | USD | 1 | us-gaap/2024 | Subsidiary Sale Of Stock= Purchase Agreement; | ||
| 0001140361-25-019266 | 20250331 | Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Connection With Private Offering And Private Placement | 5980000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Research And Development Expense Excluding Acquired In Process Cost | 7953000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Retained Earnings Accumulated Deficit | -147192000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 4370000.0000 | USD | 1 | us-gaap/2024 | Type Of Arrangement= Viatris License Agreement; | ||
| 0001140361-25-019266 | 20250331 | Shares Outstanding | 45483823.0000 | shares | 0 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Short Term Investments | 1000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20231231 | Stockholders Equity | 49906000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Stockholders Equity | -88572000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Shares At The Market Program And Purchase Agreement | 1000550.0000 | shares | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Stock Issued During Period Shares Share Based Compensation | 120516.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 5000.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Shares Stock Options Exercised | 5000.0000 | shares | 1 | us-gaap/2024 | Plan Name= Equity Incentive Plan2018; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Stock Options Exercised | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20241231 | Temporary Equity Carrying Amount Attributable To Parent | 18843000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20241231 | Temporary Equity Shares Authorized | 14146.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20241231 | Temporary Equity Shares Issued | 14145.3740 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20231231 | Temporary Equity Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20240331 | Temporary Equity Shares Outstanding | 0.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 728000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 728000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 913000.0000 | USD | 1 | us-gaap/2024 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 0.0000 | USD | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 36000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Additional Paid In Capital; | ||
| 0001140361-25-019266 | 20250331 | Assets | 48167000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20231231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 50501000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 30321000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Commitments And Contingencies | USD | 0 | us-gaap/2024 | ||||
| 0001140361-25-019266 | 20241231 | Common Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Common Stock Shares Authorized | 125000000.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Common Stock Value | 5000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Derivative Liabilities Current | 74000.0000 | USD | 0 | us-gaap/2024 | Fair Value By Fair Value Hierarchy Level= Fair Value Inputs Level3; Fair Value By Liability Class= Other Derivative Liabilities; Fair Value By Measurement Frequency= Fair Value Measurements Recurring; | ||
| 0001140361-25-019266 | 20240331 | Earnings Per Share Basic | -0.2900 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Financing Costs | 0.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20240331 | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -7106000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Income Taxes Paid Net | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Liabilities | 11295000.0000 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Net Cash Provided By Used In Investing Activities | 0.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Operating Expenses | 14299000.0000 | USD | 1 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20241231 | Preferred Stock Par Or Stated Value Per Share | 0.0001 | USD | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20250331 | Preferred Stock Shares Issued | 0.0000 | shares | 0 | us-gaap/2024 | |||
| 0001140361-25-019266 | 20240331 | Proceeds From Issuance Of Warrants In Connection With Private Offering And Private Placement | 0.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20250331 | Revenue From Contract With Customer Excluding Assessed Tax | 0.0000 | USD | 1 | us-gaap/2024 | Health Care Organization Revenue Sources= Sales Milestones; Type Of Arrangement= Viatris License Agreement; | ||
| 0001140361-25-019266 | 20240331 | Share Repurchases For Payment Of Employee Taxes | 42000.0000 | USD | 1 | 0001140361-25-019266 | |||
| 0001140361-25-019266 | 20231231 | Stockholders Equity | -81466000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Stockholders Equity | -147192000.0000 | USD | 0 | us-gaap/2024 | Equity Components= Retained Earnings; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Shares Share Based Compensation | 186919.0000 | shares | 1 | us-gaap/2024 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Issued During Period Value Of Private Offering And Private Placement | 1000.0000 | USD | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Stock Repurchases For Payment Of Employee Taxes Shares | 12965.0000 | shares | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20250331 | Stock Repurchases For Payment Of Employee Taxes Shares | 31913.0000 | shares | 1 | 0001140361-25-019266 | Equity Components= Common Stock; | ||
| 0001140361-25-019266 | 20240331 | Temporary Equity Carrying Amount Attributable To Parent | 0.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Carrying Amount Attributable To Parent | 18843000.0000 | USD | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20241031 | Temporary Equity Shares Authorized | 14146.0000 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; | ||
| 0001140361-25-019266 | 20250331 | Temporary Equity Shares Outstanding | 14145.3740 | shares | 0 | us-gaap/2024 | Class Of Stock= Series A Preferred Stock; |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| ddate | The end date for the data value, rounded to the nearest month end. |
| qtrs | The count of the number of quarters represented by the data value, rounded to the nearest whole number. “0” indicates it is a point-in-time value. |
| uom | The unit of measure for the value. |
| segments | Tags used to represent axis and member reporting. |
| coreg | If specified, indicates a specific co-registrant, the parent company, or other entity (e.g., guarantor). NULL indicates the consolidated entity. |
| value | The value. This is not scaled, it is as found in the Interactive Data file, but is limited to four digits to the right of the decimal point. |
| footnote | The text of any superscripted footnotes on the value, as shown on the statement page, truncated to 512 characters, or if there is no footnote, then this field will be blank. |
| tag | version | custom | abstract | datatype | iord | crdr | tlabel | doc |
|---|---|---|---|---|---|---|---|---|
| Increase Decrease In Accounts Receivable | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Accounts Receivable | The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services. |
| Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | C | Stock Issued During Period, Value, Stock Options Exercised | Value of stock issued as a result of the exercise of stock options. |
| Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets, Current | Amount of asset recognized for present right to economic benefit, classified as current. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents | Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Revenue from Contract with Customer, Excluding Assessed Tax | Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | 0 | 0 | monetary | D | C | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. |
| Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Adjustments to Additional Paid in Capital, Issuance Costs related to Common Stock, ATM and Registered Direct Financing | Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock and . Includes, but is not limited to, legal and accounting fees and direct costs associated with common stock; ATM and Registered Direct Financing. |
| Stock Repurchases For Payment Of Employee Taxes Shares | 0001140361-25-019266 | 1 | 0 | shares | D | Stock Repurchases for Payment of Employee Taxes, Shares | Number of shares repurchases for the payment of employee taxes. | |
| Comprehensive Income Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners. |
| Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities | Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others. |
| Liabilities And Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities and Equity | Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any. |
| Proceeds From Stock Options Exercised | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Stock Options Exercised | Amount of cash inflow from exercise of option under share-based payment arrangement. |
| Retained Earnings Accumulated Deficit | us-gaap/2024 | 0 | 0 | monetary | I | C | Retained Earnings (Accumulated Deficit) | Amount of accumulated undistributed earnings (deficit). |
| Short Term Investments | us-gaap/2024 | 0 | 0 | monetary | I | D | Short-Term Investments | Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current. |
| Temporary Equity Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Issued | The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Accrued Liabilities And Other Liabilities | us-gaap/2024 | 0 | 0 | monetary | I | C | Accrued Liabilities and Other Liabilities | Amount of expenses incurred but not yet paid nor invoiced, and liabilities classified as other. |
| Financing Costs | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Financing Costs | Amount of expense associated with the equity purchase agreement during the current accounting period. |
| Accounts Receivable Net Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Accounts Receivable, after Allowance for Credit Loss, Current | Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current. |
| Additional Paid In Capital | us-gaap/2024 | 0 | 0 | monetary | I | C | Additional Paid in Capital | Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock. |
| Common Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Common Stock, Par or Stated Value Per Share | Face amount or stated value per share of common stock. | |
| Common Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Outstanding | Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation. | |
| Derivative Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Derivative Liability, Current | Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled within one year or normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. |
| Income Tax Expense Benefit | us-gaap/2024 | 0 | 0 | monetary | D | D | Income Tax Expense (Benefit) | Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. |
| Net Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Net Income (Loss) Attributable to Parent | The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. |
| Stockholders Equity | us-gaap/2024 | 0 | 0 | monetary | I | C | Equity, Attributable to Parent | Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest. |
| Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | 0 | 0 | monetary | I | C | Temporary Equity, Carrying Amount, Attributable to Parent | Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer. |
| Temporary Equity Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Authorized | The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Diluted | The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. | |
| Assets | us-gaap/2024 | 0 | 0 | monetary | I | D | Assets | Amount of asset recognized for present right to economic benefit. |
| Common Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares, Issued | Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. | |
| Earnings Per Share Diluted | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Diluted | The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. | |
| Liabilities Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Liabilities, Current | Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. |
| Share Repurchases For Payment Of Employee Taxes | 0001140361-25-019266 | 1 | 0 | monetary | D | C | Share Repurchases for Payment of Employee Taxes | Cash outflow for share repurchases for the payment of employee taxes. |
| Preferred Stock Shares Issued | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Issued | Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt. | |
| Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | 0 | 0 | monetary | D | D | Research and Development Expense (Excluding Acquired in Process Cost) | Amount of expense for research and development. Excludes cost for computer software product to be sold, leased, or otherwise marketed, writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both, and write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity. |
| Share Based Compensation | us-gaap/2024 | 0 | 0 | monetary | D | D | Share-Based Payment Arrangement, Noncash Expense | Amount of noncash expense for share-based payment arrangement. |
| Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Temporary Equity, Par or Stated Value Per Share | Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. | |
| Unrealized Gain Loss On Investments | us-gaap/2024 | 0 | 0 | monetary | D | C | Unrealized Gain (Loss) on Investments | Amount of unrealized gain (loss) on investment. |
| Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | 0 | 0 | monetary | I | D | Cash and Cash Equivalents, at Carrying Value | Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation. |
| Stock Issued During Period Shares Of Private Offering And Private Placement | 0001140361-25-019266 | 1 | 0 | shares | D | Stock Issued During Period Shares of Private Offering and Private Placement | Number of new stock issued in connection with private offering and private placement during the period. | |
| Income Taxes Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Income Taxes Paid, Net | Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax. |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | 0 | 0 | monetary | D | C | Increase (Decrease) in Prepaid Expense and Other Assets | Amount of increase (decrease) in prepaid expenses, and assets classified as other. |
| Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Comprehensive Income (Loss), Net of Tax | Amount after tax and reclassification adjustments of other comprehensive income (loss). |
| Payments Of Stock Issuance Costs | us-gaap/2024 | 0 | 0 | monetary | D | C | Payments of Stock Issuance Costs | The cash outflow for cost incurred directly with the issuance of an equity security. |
| Preferred Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Preferred Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | Amount of decrease in additional paid in capital (APIC) resulting from share repurchases for the payment of employee taxes. |
| Increase Decrease In Contract Assets And Unbilled Receivables | 0001140361-25-019266 | 1 | 0 | monetary | D | C | Increase (Decrease) in Contract Assets and Unbilled Receivables | The increase (decrease) during the reporting period in contract assets and unbilled receivables arising from the contracting of goods and services and for work performed for which billing has not occurred, net for uncollectible accounts. |
| Stock Issued During Period Value Of Private Offering And Private Placement | 0001140361-25-019266 | 1 | 0 | monetary | D | C | Stock Issued During Period Value of Private Offering and Private Placement | Equity impact of the value of new stock issued in connection with private offering and private placement during the period. |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | 0 | 0 | monetary | D | D | Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. |
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | Amount of increase (decrease) in accrued expenses, and obligations classified as other. |
| Net Cash Provided By Used In Operating Activities | us-gaap/2024 | 0 | 0 | monetary | D | Net Cash Provided by (Used in) Operating Activities | Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. | |
| Operating Expenses | us-gaap/2024 | 0 | 0 | monetary | D | D | Operating Expenses | Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. |
| Operating Income Loss | us-gaap/2024 | 0 | 0 | monetary | D | C | Operating Income (Loss) | The net result for the period of deducting operating expenses from operating revenues. |
| Prepaid Expense And Other Assets Current | us-gaap/2024 | 0 | 0 | monetary | I | D | Prepaid Expense and Other Assets, Current | Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer. |
| Temporary Equity Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Temporary Equity, Shares Outstanding | The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer. | |
| Stock Issued During Period Shares At The Market Program And Purchase Agreement | 0001140361-25-019266 | 1 | 0 | shares | D | Stock Issued During Period Shares at-the-Market Program and Purchase Agreement | Number of new stock issued in connection with the at-the-market program and purchase agreement during the period. | |
| Common Stock Value | us-gaap/2024 | 0 | 0 | monetary | I | C | Common Stock, Value, Issued | Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. |
| General And Administrative Expense | us-gaap/2024 | 0 | 0 | monetary | D | D | General and Administrative Expense | The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. |
| Contract Assets And Unbilled Receivables Current | 0001140361-25-019266 | 1 | 0 | monetary | I | D | Contract Assets and Unbilled Receivables, Current | Contract assets and unbilled receivables are recognized when goods or services are transferred to the customer before the customer pays or before reimbursement for payment is billed or due, excluding any amounts presented as an account receivable, for contractual agreements due within one year or the normal operating cycle, if longer. |
| Warrant Financing Costs Reclassified To Financing Activities | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Warrant Financing Costs Reclassified to Financing Activities | The amount warrant financing costs reclassified to financing activities. |
| Accounts Payable Current | us-gaap/2024 | 0 | 0 | monetary | I | C | Accounts Payable, Current | Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). |
| Commitments And Contingencies | us-gaap/2024 | 0 | 0 | monetary | I | C | Commitments and Contingencies | Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. |
| Common Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Common Stock, Shares Authorized | The maximum number of common shares permitted to be issued by an entity's charter and bylaws. | |
| Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | 0 | 0 | monetary | D | C | Gain (Loss) on Derivative Instruments, Net, Pretax | Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. |
| Increase Decrease In Accounts Payable | us-gaap/2024 | 0 | 0 | monetary | D | D | Increase (Decrease) in Accounts Payable | The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. |
| Interest Paid Net | us-gaap/2024 | 0 | 0 | monetary | D | C | Interest Paid, Excluding Capitalized Interest, Operating Activities | Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount. |
| Net Cash Provided By Used In Financing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Financing Activities | Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. |
| Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | 0 | 0 | perShare | I | Preferred Stock, Par or Stated Value Per Share | Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. | |
| Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Shares, Outstanding | Number of shares issued which are neither cancelled nor held in the treasury. | |
| Proceeds From Issuance Of Warrants In Connection With Private Offering And Private Placement | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Proceeds from Issuance of Warrants in Connection with Private Offering and Private Placement | The cash inflow from issuance of rights to purchase common shares in connection with private offering and private placement. |
| Unpaid Issuance Costs | 0001140361-25-019266 | 1 | 0 | monetary | D | C | Unpaid Issuance Costs | Unpaid issuance costs related to equity transactions. |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | 0 | 0 | monetary | D | C | APIC, Share-Based Payment Arrangement, Increase for Cost Recognition | Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. |
| Depreciation | us-gaap/2024 | 0 | 0 | monetary | D | D | Depreciation | The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation. |
| Earnings Per Share Basic | us-gaap/2024 | 0 | 0 | perShare | D | Earnings Per Share, Basic | The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. | |
| Net Cash Provided By Used In Investing Activities | us-gaap/2024 | 0 | 0 | monetary | D | D | Net Cash Provided by (Used in) Investing Activities | Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. |
| Other Nonoperating Income Expense | us-gaap/2024 | 0 | 0 | monetary | D | C | Other Nonoperating Income (Expense) | Amount of income (expense) related to nonoperating activities, classified as other. |
| Preferred Stock Shares Authorized | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Authorized | The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. | |
| Preferred Stock Shares Outstanding | us-gaap/2024 | 0 | 0 | shares | I | Preferred Stock, Shares Outstanding | Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. | |
| Proceeds From Issuance Of Common Stock | us-gaap/2024 | 0 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock | The cash inflow from the additional capital contribution to the entity. |
| Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | 0 | 0 | shares | D | Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period | Number of share options (or share units) exercised during the current period. | |
| Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Connection With Private Offering And Private Placement | 0001140361-25-019266 | 1 | 0 | monetary | D | D | Proceeds from Issuance of Common Stock and Pre-funded Warrants in Connection with Private Offering and Private Placement | The cash inflow from the additional capital contribution to the entity in connection with private offering and private placement. |
| Stock Issued During Period Value At The Market Program And Purchase Agreement | 0001140361-25-019266 | 1 | 0 | monetary | D | C | Stock Issued During Period Value at-the-Market Program and Purchase Agreement | Equity impact of the value of new stock issued in connection with the at-the-market program and purchase agreement during the period. |
| Property Plant And Equipment Net | us-gaap/2024 | 0 | 0 | monetary | I | D | Property, Plant and Equipment, Net | Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures. |
| Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | 0 | 0 | shares | D | Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture | Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP). | |
| Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | 0 | 0 | shares | D | Weighted Average Number of Shares Outstanding, Basic | Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. |
| Field Name | Field Description |
|---|---|
| tag | The unique identifier (name) for a tag in a specific taxonomy release. |
| version | For a standard tag, an identifier for the taxonomy; otherwise the accession number where the tag was defined. |
| custom | 1 if tag is custom (version=adsh), 0 if it is standard. Note: This flag is technically redundant with the version and adsh columns. |
| abstract | 1 if the tag is not used to represent a numeric fact. |
| datatype | If abstract=1, then NULL, otherwise the data type (e.g., monetary) for the tag. |
| iord | If abstract=1, then NULL; otherwise, “I” if the value is a point-in time, or “D” if the value is a duration. |
| crdr | If datatype = monetary, then the tag’s natural accounting balance (debit or credit); if not defined, then NULL. |
| tlabel | If a standard tag, then the label text provided by the taxonomy, otherwise the text provided by the filer. A tag which had neither would have a NULL value here. |
| doc | The detailed definition for the tag. If a standard tag, then the text provided by the taxonomy, otherwise the text assigned by the filer. Some tags have neither, and this field is NULL. |
| adsh | report | line | stmt | inpth | rfile | tag | version | plabel | negating |
|---|---|---|---|---|---|---|---|---|---|
| 0001140361-25-019266 | 2 | 3 | BS | 0 | H | Cash And Cash Equivalents At Carrying Value | us-gaap/2024 | Cash and cash equivalents | 0 |
| 0001140361-25-019266 | 2 | 4 | BS | 0 | H | Accounts Receivable Net Current | us-gaap/2024 | Accounts receivable | 0 |
| 0001140361-25-019266 | 2 | 5 | BS | 0 | H | Contract Assets And Unbilled Receivables Current | 0001140361-25-019266 | Contract assets and unbilled receivables (Note 10) | 0 |
| 0001140361-25-019266 | 2 | 6 | BS | 0 | H | Prepaid Expense And Other Assets Current | us-gaap/2024 | Prepaids and other current assets | 0 |
| 0001140361-25-019266 | 2 | 7 | BS | 0 | H | Short Term Investments | us-gaap/2024 | Short-term investments | 0 |
| 0001140361-25-019266 | 2 | 8 | BS | 0 | H | Assets Current | us-gaap/2024 | Total current assets | 0 |
| 0001140361-25-019266 | 2 | 9 | BS | 0 | H | Property Plant And Equipment Net | us-gaap/2024 | Property and equipment, net | 0 |
| 0001140361-25-019266 | 2 | 10 | BS | 0 | H | Assets | us-gaap/2024 | Total assets | 0 |
| 0001140361-25-019266 | 2 | 13 | BS | 0 | H | Accounts Payable Current | us-gaap/2024 | Accounts payable | 0 |
| 0001140361-25-019266 | 2 | 14 | BS | 0 | H | Accrued Liabilities And Other Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0001140361-25-019266 | 2 | 15 | BS | 0 | H | Derivative Liabilities Current | us-gaap/2024 | Warrant liabilities | 0 |
| 0001140361-25-019266 | 2 | 16 | BS | 0 | H | Liabilities Current | us-gaap/2024 | Total current liabilities | 0 |
| 0001140361-25-019266 | 2 | 17 | BS | 0 | H | Liabilities | us-gaap/2024 | Total liabilities | 0 |
| 0001140361-25-019266 | 2 | 18 | BS | 0 | H | Commitments And Contingencies | us-gaap/2024 | Commitments and contingencies (Note 3 and Note 9) | 0 |
| 0001140361-25-019266 | 2 | 19 | BS | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Series A preferred stock, par value $0.0001; 14,146 shares were designated as of March 31, 2025 and December 31, 2024; 14,145.374 shares issued and outstanding at March 31, 2025 and December 31, 2024. | 0 |
| 0001140361-25-019266 | 2 | 21 | BS | 0 | H | Preferred Stock Value | us-gaap/2024 | Preferred stock, par value $0.0001; 9,985,854 shares authorized as of March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024. | 0 |
| 0001140361-25-019266 | 2 | 22 | BS | 0 | H | Common Stock Value | us-gaap/2024 | Common stock, par value $0.0001; 125,000,000 shares authorized as of March 31, 2025 and December 31, 2024; 45,483,823 and 31,574,657 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively. | 0 |
| 0001140361-25-019266 | 2 | 23 | BS | 0 | H | Additional Paid In Capital | us-gaap/2024 | Additional paid-in capital | 0 |
| 0001140361-25-019266 | 2 | 24 | BS | 0 | H | Retained Earnings Accumulated Deficit | us-gaap/2024 | Accumulated deficit | 0 |
| 0001140361-25-019266 | 2 | 25 | BS | 0 | H | Stockholders Equity | us-gaap/2024 | Total stockholders' equity | 0 |
| 0001140361-25-019266 | 2 | 26 | BS | 0 | H | Liabilities And Stockholders Equity | us-gaap/2024 | Total liabilities, series A preferred stock, and stockholders' equity | 0 |
| 0001140361-25-019266 | 3 | 7 | BS | 1 | H | Temporary Equity Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001140361-25-019266 | 3 | 8 | BS | 1 | H | Temporary Equity Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001140361-25-019266 | 3 | 9 | BS | 1 | H | Temporary Equity Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001140361-25-019266 | 3 | 10 | BS | 1 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001140361-25-019266 | 3 | 12 | BS | 1 | H | Preferred Stock Par Or Stated Value Per Share | us-gaap/2024 | Preferred stock, par value (in dollars per share) | 0 |
| 0001140361-25-019266 | 3 | 13 | BS | 1 | H | Preferred Stock Shares Authorized | us-gaap/2024 | Preferred stock, shares authorized (in shares) | 0 |
| 0001140361-25-019266 | 3 | 14 | BS | 1 | H | Preferred Stock Shares Issued | us-gaap/2024 | Preferred stock, shares issued (in shares) | 0 |
| 0001140361-25-019266 | 3 | 15 | BS | 1 | H | Preferred Stock Shares Outstanding | us-gaap/2024 | Preferred stock, shares outstanding (in shares) | 0 |
| 0001140361-25-019266 | 3 | 16 | BS | 1 | H | Common Stock Par Or Stated Value Per Share | us-gaap/2024 | Common stock, par value (in dollars per share) | 0 |
| 0001140361-25-019266 | 3 | 17 | BS | 1 | H | Common Stock Shares Authorized | us-gaap/2024 | Common stock, shares authorized (in shares) | 0 |
| 0001140361-25-019266 | 3 | 18 | BS | 1 | H | Common Stock Shares Issued | us-gaap/2024 | Common stock, shares issued (in shares) | 0 |
| 0001140361-25-019266 | 3 | 19 | BS | 1 | H | Common Stock Shares Outstanding | us-gaap/2024 | Common stock, shares outstanding (in shares) | 0 |
| 0001140361-25-019266 | 4 | 1 | IS | 0 | H | Revenue From Contract With Customer Excluding Assessed Tax | us-gaap/2024 | License and collaborations revenue | 0 |
| 0001140361-25-019266 | 4 | 3 | IS | 0 | H | General And Administrative Expense | us-gaap/2024 | General and administrative | 0 |
| 0001140361-25-019266 | 4 | 4 | IS | 0 | H | Research And Development Expense Excluding Acquired In Process Cost | us-gaap/2024 | Research and development | 0 |
| 0001140361-25-019266 | 4 | 5 | IS | 0 | H | Operating Expenses | us-gaap/2024 | Total operating expenses | 0 |
| 0001140361-25-019266 | 4 | 6 | IS | 0 | H | Operating Income Loss | us-gaap/2024 | Loss from operations | 0 |
| 0001140361-25-019266 | 4 | 7 | IS | 0 | H | Financing Costs | 0001140361-25-019266 | Financing costs | 1 |
| 0001140361-25-019266 | 4 | 8 | IS | 0 | H | Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | Fair value change in warrant liabilities | 0 |
| 0001140361-25-019266 | 4 | 9 | IS | 0 | H | Other Nonoperating Income Expense | us-gaap/2024 | Other income, net | 0 |
| 0001140361-25-019266 | 4 | 10 | IS | 0 | H | Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | us-gaap/2024 | Loss before income taxes | 0 |
| 0001140361-25-019266 | 4 | 11 | IS | 0 | H | Income Tax Expense Benefit | us-gaap/2024 | Benefit (provision) for income taxes | 1 |
| 0001140361-25-019266 | 4 | 12 | IS | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001140361-25-019266 | 4 | 13 | IS | 0 | H | Other Comprehensive Income Loss Net Of Tax | us-gaap/2024 | Other comprehensive loss, net of tax | 0 |
| 0001140361-25-019266 | 4 | 14 | IS | 0 | H | Comprehensive Income Net Of Tax | us-gaap/2024 | Comprehensive loss | 0 |
| 0001140361-25-019266 | 4 | 16 | IS | 0 | H | Earnings Per Share Basic | us-gaap/2024 | Basic (in dollars per share) Note 11 | 0 |
| 0001140361-25-019266 | 4 | 17 | IS | 0 | H | Earnings Per Share Diluted | us-gaap/2024 | Diluted (in dollars per share) Note 11 | 0 |
| 0001140361-25-019266 | 4 | 19 | IS | 0 | H | Weighted Average Number Of Shares Outstanding Basic | us-gaap/2024 | Basic (in shares) | 0 |
| 0001140361-25-019266 | 4 | 20 | IS | 0 | H | Weighted Average Number Of Diluted Shares Outstanding | us-gaap/2024 | Diluted (in shares) | 0 |
| 0001140361-25-019266 | 5 | 12 | EQ | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Balance | 0 |
| 0001140361-25-019266 | 5 | 13 | EQ | 0 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0001140361-25-019266 | 5 | 14 | EQ | 0 | H | Temporary Equity Carrying Amount Attributable To Parent | us-gaap/2024 | Balance | 0 |
| 0001140361-25-019266 | 5 | 15 | EQ | 0 | H | Temporary Equity Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0001140361-25-019266 | 5 | 17 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001140361-25-019266 | 5 | 18 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0001140361-25-019266 | 5 | 19 | EQ | 0 | H | Stock Issued During Period Value Of Private Offering And Private Placement | 0001140361-25-019266 | Issuance of common stock and pre-funded warrants in connection with the March 2025 offering and private placement | 0 |
| 0001140361-25-019266 | 5 | 20 | EQ | 0 | H | Stock Issued During Period Shares Of Private Offering And Private Placement | 0001140361-25-019266 | Issuance of common stock and pre-funded warrants in connection with the March 2025 offering and March 2025 private placement (in shares) | 0 |
| 0001140361-25-019266 | 5 | 21 | EQ | 0 | H | Stock Issued During Period Value At The Market Program And Purchase Agreement | 0001140361-25-019266 | Issuance of common stock in connection with the at-the-market program and purchase agreement | 0 |
| 0001140361-25-019266 | 5 | 22 | EQ | 0 | H | Stock Issued During Period Shares At The Market Program And Purchase Agreement | 0001140361-25-019266 | Issuance of common stock in connection with the at-the-market program and purchase agreement (in shares) | 0 |
| 0001140361-25-019266 | 5 | 23 | EQ | 0 | H | Adjustments To Additional Paid In Capital Issuance Costs Related To Common Stock A T M And Registered Direct Financing | 0001140361-25-019266 | Issuance costs | 1 |
| 0001140361-25-019266 | 5 | 24 | EQ | 0 | H | Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | us-gaap/2024 | Stock-based compensation | 0 |
| 0001140361-25-019266 | 5 | 25 | EQ | 0 | H | Stock Issued During Period Shares Share Based Compensation | us-gaap/2024 | Stock-based compensation (in shares) | 0 |
| 0001140361-25-019266 | 5 | 26 | EQ | 0 | H | Adjustments To Additional Paid In Capital Share Repurchases For Payment Of Employee Taxes | 0001140361-25-019266 | Share repurchases for the payment of employee taxes | 1 |
| 0001140361-25-019266 | 5 | 27 | EQ | 0 | H | Stock Repurchases For Payment Of Employee Taxes Shares | 0001140361-25-019266 | Share repurchases for the payment of employee taxes (in shares) | 1 |
| 0001140361-25-019266 | 5 | 28 | EQ | 0 | H | Stock Issued During Period Value Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0001140361-25-019266 | 5 | 29 | EQ | 0 | H | Stock Issued During Period Shares Stock Options Exercised | us-gaap/2024 | Exercise of stock options (in shares) | 0 |
| 0001140361-25-019266 | 5 | 30 | EQ | 0 | H | Net Income Loss | us-gaap/2024 | Net and comprehensive loss | 0 |
| 0001140361-25-019266 | 5 | 31 | EQ | 0 | H | Stockholders Equity | us-gaap/2024 | Balance | 0 |
| 0001140361-25-019266 | 5 | 32 | EQ | 0 | H | Shares Outstanding | us-gaap/2024 | Balance (in shares) | 0 |
| 0001140361-25-019266 | 6 | 2 | CF | 0 | H | Net Income Loss | us-gaap/2024 | Net loss | 0 |
| 0001140361-25-019266 | 6 | 4 | CF | 0 | H | Share Based Compensation | us-gaap/2024 | Stock-based compensation | 0 |
| 0001140361-25-019266 | 6 | 5 | CF | 0 | H | Depreciation | us-gaap/2024 | Depreciation | 0 |
| 0001140361-25-019266 | 6 | 6 | CF | 0 | H | Gain Loss On Derivative Instruments Net Pretax | us-gaap/2024 | Fair value change in warrant liabilities | 1 |
| 0001140361-25-019266 | 6 | 7 | CF | 0 | H | Unrealized Gain Loss On Investments | us-gaap/2024 | Unrealized loss from short-term investments | 1 |
| 0001140361-25-019266 | 6 | 8 | CF | 0 | H | Warrant Financing Costs Reclassified To Financing Activities | 0001140361-25-019266 | Warrant financing costs | 0 |
| 0001140361-25-019266 | 6 | 10 | CF | 0 | H | Increase Decrease In Accounts Receivable | us-gaap/2024 | Accounts receivable | 1 |
| 0001140361-25-019266 | 6 | 11 | CF | 0 | H | Increase Decrease In Contract Assets And Unbilled Receivables | 0001140361-25-019266 | Contract assets and unbilled receivables | 1 |
| 0001140361-25-019266 | 6 | 12 | CF | 0 | H | Increase Decrease In Prepaid Deferred Expense And Other Assets | us-gaap/2024 | Prepaid expenses and other assets | 1 |
| 0001140361-25-019266 | 6 | 13 | CF | 0 | H | Increase Decrease In Accounts Payable | us-gaap/2024 | Accounts payable | 0 |
| 0001140361-25-019266 | 6 | 14 | CF | 0 | H | Increase Decrease In Accrued Liabilities And Other Operating Liabilities | us-gaap/2024 | Accrued expenses and other liabilities | 0 |
| 0001140361-25-019266 | 6 | 15 | CF | 0 | H | Net Cash Provided By Used In Operating Activities | us-gaap/2024 | Net cash used in operating activities | 0 |
| 0001140361-25-019266 | 6 | 17 | CF | 0 | H | Net Cash Provided By Used In Investing Activities | us-gaap/2024 | Net cash used in investing activities | 0 |
| 0001140361-25-019266 | 6 | 19 | CF | 0 | H | Proceeds From Issuance Of Common Stock And Pre Funded Warrants In Connection With Private Offering And Private Placement | 0001140361-25-019266 | Proceeds from issuance of common stock and pre-funded warrants in connection with the March 2025 offering and March 2025 private placement | 0 |
| 0001140361-25-019266 | 6 | 20 | CF | 0 | H | Proceeds From Issuance Of Warrants In Connection With Private Offering And Private Placement | 0001140361-25-019266 | Proceeds from issuance of warrants in connection with the March 2025 offering and March 2025 private placement | 0 |
| 0001140361-25-019266 | 6 | 21 | CF | 0 | H | Proceeds From Issuance Of Common Stock | us-gaap/2024 | Proceeds from issuance of common stock in connection with the at-the-market program and purchase agreement | 0 |
| 0001140361-25-019266 | 6 | 22 | CF | 0 | H | Payments Of Stock Issuance Costs | us-gaap/2024 | Issuance costs | 1 |
| 0001140361-25-019266 | 6 | 23 | CF | 0 | H | Proceeds From Stock Options Exercised | us-gaap/2024 | Exercise of stock options | 0 |
| 0001140361-25-019266 | 6 | 24 | CF | 0 | H | Share Repurchases For Payment Of Employee Taxes | 0001140361-25-019266 | Share repurchases for the payment of employee taxes | 1 |
| 0001140361-25-019266 | 6 | 25 | CF | 0 | H | Net Cash Provided By Used In Financing Activities | us-gaap/2024 | Net cash provided by financing activities | 0 |
| 0001140361-25-019266 | 6 | 26 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect | us-gaap/2024 | Net increase (decrease) in cash and cash equivalents | 0 |
| 0001140361-25-019266 | 6 | 27 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at beginning of period | 0 |
| 0001140361-25-019266 | 6 | 28 | CF | 0 | H | Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | us-gaap/2024 | Cash and cash equivalents at end of period | 0 |
| 0001140361-25-019266 | 6 | 30 | CF | 0 | H | Income Taxes Paid Net | us-gaap/2024 | Cash paid for income taxes | 0 |
| 0001140361-25-019266 | 6 | 31 | CF | 0 | H | Interest Paid Net | us-gaap/2024 | Cash paid for interest | 0 |
| 0001140361-25-019266 | 6 | 33 | CF | 0 | H | Unpaid Issuance Costs | 0001140361-25-019266 | Unpaid issuance costs | 0 |
| Field Name | Field Description |
|---|---|
| adsh | Accession Number. The 20-character string formed from the 18-digit number assigned by the SEC to each EDGAR submission. |
| report | Represents the report grouping. This field corresponds to the statement (stmt) field, which indicates the type of statement. The numeric value refers to the “R file” as posted on the EDGAR Web site. |
| line | Represents the tag’s presentation line order for a given report. Together with the statement and report field, presentation location, order and grouping can be derived. |
| stmt | The financial statement location to which the value of the “report” field pertains. |
| inpth | Value was presented “parenthetically” instead of in columns within the financial statements. For example: Receivables (net of allowance for bad debts of $200 in 2012) $700. |
| rfile | The type of interactive data file rendered on the EDGAR web site, H = .htm file, X = .xml file. |
| tag | The tag chosen by the filer for this line item. |
| version | The taxonomy identifier if the tag is a standard tag, otherwise adsh. |
| plabel | The text presented on the line item, also known as a “preferred” label. |
| negating | Flag to indicate whether the plabel is negating. |